← Evidence map

ArticleJournal of the Canadian Association of Gastroenterology2020

Cost of Refractory Crohn's Disease Before and After Ustekinumab Utilization.

Elham Rahme et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 33241178